Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | SLC2A1 | P11166 | 2/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.38 |
| ▸ | ABCC1 | P33527 | 1/20 | 0.38 |
| ▸ | MAP2K3 | P46734 | 1/20 | 0.38 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.37 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23914366 | 0.84 | CYP2C19 (0.41) | ALDH1A1CYP2C19LMNACYP1A1CYP1B1 | |
| SCHEMBL23913799 | 0.82 | ALDH1A1 (0.43) | ALDH1A1KDM4ESLC2A1ABCC1MAP2K3 | |
| SCHEMBL23914096 | 0.82 | MEN1 (0.40) | ALDH1A1KDM4ECYP2C19LMNA | |
| SCHEMBL23914441 | 0.82 | CYP2C19 (0.48) | ALDH1A1KDM4ECYP2C19LMNA | |
| SCHEMBL23914355 | 0.81 | P2RX3 (0.42) | LMNA | |
| SCHEMBL23914083 | 0.73 | ALDH1A1 (0.45) | ALDH1A1KDM4ELMNA | |
| SCHEMBL23913947 | 0.70 | ALDH1A1 (0.52) | ALDH1A1KDM4ELMNAABCB1 | |
| SCHEMBL23914088 | 0.70 | ALDH1A1 (0.52) | ALDH1A1KDM4ELMNAABCB1 | |
| SCHEMBL23913793 | 0.69 | ACHE (0.44) | ALDH1A1LMNA | |
| SCHEMBL23914267 | 0.68 | KMT2A (0.44) | ALDH1A1CYP2C19LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210317099-A1 | SAFER, POTENT, AND FAST ACTING ANTIMICROBIAL AGENTS | PURDUE RESEARCH FOUNDATION (US) | 2021-10-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210317099-A1 | SAFER, POTENT, AND FAST ACTING ANTIMICROBIAL AGENTS | MIF, LTA, MGAM | ALDH1A1 2164/4885KDM4E 2541/4885SLC2A1 4130/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.